GH Research PLC Ordinary Shares (GHRS) is a publicly traded Healthcare sector company. As of September 11, 2026, GHRS trades at $28.39 with a market cap of $1.89B and a P/E ratio of 0.00. GHRS moved +4.07% today. Year to date, GHRS is +106.04%; over the trailing twelve months it is +111.64%. Its 52-week range spans $7.98 to $31.44. Analyst consensus is strong buy with an average price target of $43.38. Rallies surfaces GHRS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for GHRS, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $28.39 |
| Market Cap | $1.89B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $31.44 |
| 52-Week Low | $7.98 |
| Volume | 5 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
9 analysts cover GHRS: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $43.38.